Financials

  • Market Capitalization 44 M
  • Employee 228
  • Founded 2008
  • CEO N/A
  • Website www.karyopharm.com
  • Headquarter Delaware, United States
  • FIGI BBG001J272L7
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.41
Rapporto prezzo/fatturato
0

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4314
ALGS
Aligos Therapeutics, Inc. - Common stock
7.07 USD-5.86%+9.10%+68.33%-27.78%44.09 M USD
4315
TVGN
Tevogen Bio Holdings Inc. - Common Stock
6.76 USD+0.90%+8.51%+20.93%+651.11%44.02 M USD
4325
MREO
Mereo BioPharma Group plc - American Depositary Shares
0.27 USD-3.57%-12.90%-12.90%-84.57%43.12 M USD
4343
ACTU
Actuate Therapeutics, Inc. - Common stock
1.69 USD-5.06%+38.52%+55.05%-58.58%40.58 M USD

Notizie